Last reviewed: September 22, 2025 What this article covers: why the psychedelic facilitator–client relationship is often more important than the medicine itself, what training and qualities matter most, how cultural fit shapes outcomes, and how seekers can evaluate...
FDA Publishes MDMA CRL, Exposes Safety and Durability Concerns for Psychedelic Therapies The US Food and Drug Administration announced on September 4, 2025 that it will publish Complete Response Letters promptly after they are issued, and it released a batch of 89...
In recent years, ketamine therapy has emerged as one of the most promising tools in the psychedelic-assisted therapy landscape. Originally developed as an anesthetic, ketamine is now showing remarkable potential for conditions like depression, PTSD, and...
It starts innocently enough. You’re prepping for a solo psilocybin experience. You dim the lights, queue your playlist, and open an app that promises structured prompts, real-time check-ins, and therapeutic journaling support. No human needed. It’s like having a guide...
When Nico sat across from his psychiatrist after trying yet another antidepressant that didn’t work, he wasn’t angry—he was numb. Thirty years of depression had taught him to live in grayscale. Therapy, medications, even TMS had provided temporary relief, but...
Curious about psychedelic therapy but not sure who or what to trust? You’re not alone. From podcasts to documentaries, plant medicines like psilocybin and MDMA are showing up everywhere—and now, they’ve entered the political arena. In a recent AP article,...
